Mahamaya Lifesciences
add_icon

Mahamaya Lifesciences

182.00
-4.00
(-2.15%)
Market Cap
425.94 Cr
PE Ratio
33.63
Volume
12,000.00
Day High - Low
185.00 - 180.60
52W High-Low
205.05 - 111.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
425.94 Cr
EPS
7.60
PE Ratio
33.63
PB Ratio
3.83
Book Value
48.58
EBITDA
26.00
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
26.19
Debt to Equity
1.52
Forecast For
Actual

Company News

View All News
Caret
neutral
Mahamaya Lifesciences Limited informs BSE about exemption from corporate governance compliance requirements under SEBI regulations due to BSE SME platform listing status.
neutral
Mahamaya Lifesciences Limited submitted its quarterly compliance certificate under SEBI regulations for Q4FY26, confirming all shares remain in demat form with no rematerialization requests received.
neutral
Mahamaya Lifesciences Limited submits annual disclosure under SEBI regulations confirming no encumbrance on promoter shares during FY26, maintaining regulatory compliance.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
641.85
#1 54,183.00
27.11
#1 47,123.00
8.13
820
-42.56
50.40
3,054.80
46,346.85
32.31
8,322.00
5.70
#1 1,660
-16.47
54.31
4,764.10
21,410.86
31.34
5,593.10
7.89
568
179.82
52.83
419.15
20,921.69
40.98
3,268.60
11.19
506
-13.27
49.51
1,072.75
9,678.40
18.34
4,379.40
#1 35.89
304
#1 366.56
50.36
265.91
5,171.12
31.33
2,631.40
6.54
164
-274.07
58.23
1,079.65
4,866.88
#1 15.99
2,071.30
15.49
297
27.97
62.64
161.32
3,775.10
-84.03
1,242.60
-30.48
-92
71.82
56.34
264.91
3,435.06
261.13
449.80
9.63
14
27.78
67.99
1,384.70
2,301.52
17.28
1,199.00
12.53
141
-1.23
42.97
Growth Rate
Revenue Growth
64.13 %
Net Income Growth
148.08 %
Cash Flow Change
102.29 %
ROE
23.77 %
ROCE
11.19 %
EBITDA Margin (Avg.)
9.09 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Revenue
0
120
Expenses
0
108
EBITDA
0
12
Operating Profit %
0 %
8 %
Depreciation
0
1
Interest
0
3
Profit Before Tax
0
7
Tax
0
2
Net Profit
0
6
EPS in ₹
0.00
3.11

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
56
78
112
188
Fixed Assets
20
21
22
27
Current Assets
33
54
87
157
Capital Work in Progress
2
2
3
4
Investments
0
0
0
0
Other Assets
34
54
88
157
Total Equity & Liabilities
56
78
112
188
Current Liabilities
30
48
78
132
Non Current Liabilities
10
11
9
7
Total Equity
16
19
25
49
Reserve & Surplus
15
18
23
32
Share Capital
1
1
1
18

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
1
-0
1
Investing Activities
-3
-3
-2
-8
Operating Activities
2
1
-23
1
Financing Activities
1
2
24
9

Share Holding

% Holding
Feb 2025
Oct 2025
Nov 2025
Mar 2026
Promoter
77.27 %
77.27 %
56.35 %
56.35 %
FIIs
0.00 %
0.00 %
6.39 %
4.77 %
DIIs
0.00 %
0.00 %
4.67 %
2.52 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
12.72 %
10.65 %
Others
22.73 %
22.73 %
19.88 %
25.71 %
No of Share Holders
18
18
1,034
584

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Dec 2025 116.35 115.55

Announcements

Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work"2 days ago
Non-Applicability Of The Compliance On Corporate Governance As Required Under Regulation 27(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011Apr 03, 2026
Closure of Trading WindowMar 30, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Utilisation Of Unutilised IPO Proceeds In Subsequent Fiscal Years.Mar 10, 2026
Announcement Under Regulation 30 (LODR)-Intimation Of Withdrawn Of Participation In Virtual Conference On Monday 9" March 2026.Mar 09, 2026
Intimation Of Participation In Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 On Monday 9Th March 2026.Mar 05, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP)Feb 17, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP)Feb 17, 2026
Announcement Under Regulation 30 - Receiving A Prestigious Award - Company Of The Year - Medium Scale At ICSCE 2026 DubaiJan 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Submission Of Half Yearly Financial Results - September 2025Dec 02, 2025
Board Meeting Outcome for Submission Of Half Year Results - September 2025Dec 02, 2025
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial ResultsNov 26, 2025
Closure of Trading WindowNov 24, 2025
Listing of Equity Shares of Mahamaya Lifesciences LtdNov 18, 2025

Technical Indicators

RSI(14)
Neutral
61.96
ATR(14)
Less Volatile
7.99
STOCH(9,6)
Neutral
65.70
STOCH RSI(14)
Neutral
49.86
MACD(12,26)
Bullish
1.75
ADX(14)
Strong Trend
44.00
UO(9)
Bearish
53.17
ROC(12)
Uptrend And Accelerating
7.48
WillR(14)
Neutral
-34.21